1.The design and development of a portable thermostat apparatus for medical liquid based on Single-Chip-Microprocessor
Wenxu GUO ; Qingkui CHEN ; Xinzheng LI
China Medical Equipment 2016;13(5):14-16
Objective:Some medical liquid needs to be heated to the human body temperature, so the constant temperature case is a necessary equipment. But the common constant temperature case is often bulky, inconvenient application and the price is very high, so this paper is mainly to develop a convenient and cheap thermostat device for medical liquid heating.Methods:The system used single-chip microcomputer for temperature control. The temperature sensor collected and displayed the temperature of the box when the temperature was set up. Then the heating module started when the temperature was lower than the set point, and stopped heating when reaching to the set point.Results: The temperature control effect of constant temperature case tested by calibrated mercury thermometer, the temperature of constant temperature case was not significantly different from that of mercury thermometer.Conclusion: The portable constant temperature case for medical liquid have the characteristics of precise temperature control, high temperature resolution, and small temperature fluctuations. It can meet the clinical needs and be worth to popularizing in clinical applications.
2.Introduction of high frequency electro-surgical unit safety operation
Qingkui CHEN ; Wenxu GUO ; Shike QIU
China Medical Equipment 2013;(11):117-117,118
To introducethe high frequency electro-surgical unit safety operation, reduce the pain of the patients, to maximize the effect of high frequency electro-surgical unit.
3.Therapeutic effect of inhaled aerosolized versus intravenous milrinone on postoperative pulmonary artery hypertension in children with congenital heart disease
Ning YIN ; Jue CHEN ; Xiaohua SHI ; Li ZHOU ; Junling WANG ; Weifeng LU ; Shan ZHONG ; Li ZHANG ; Wenxu JIANG ; Lingling CHEN ; Hongqiang HUANG
Chinese Journal of Anesthesiology 2010;30(11):1281-1283
Objective To compare the therapeutic effect of inhaled aerosolized and intravenous milrinone (a phosphodiesteraee-3 inhibitor) on postoperative pulmonary artery hypertension (PAH) in children with congenital heart disease (CHD).Methods Forty CHD complicated with PAH children aged 5-14 yr weighing 15-38 kg with pulmonary artery pressure (PAP) 30-90 mm Hg were randomly divided into 2 groups (n = 20 each): Ⅰ milrinone inhalation group and Ⅱ intravenous milrinone group. At the end of CPB, aerosolized milrinone 1 ml/kg was inhaled for 12 h at 30 min intervals, and each time milrinone was inhaled for 10 min in group Ⅰ . In group Ⅱ , a bolus of 10 g/kg milrinone was given iv followed by 12 h milrinone infusion at 0.5 μg·kg-1 ·min-1 . Blood samples were taken from aorta and pulmonary artery for blood gas analysis at the end of administration and venous oxygen saturation (S(-v)O2) was recorded. MAP, PAP, pulmonary vascular resistance index (PVRI) and systemic vascular resistance index (SVRI) were recorded every 2 h during milrinone administration. The duration of endotracheal tube, PAH, lung infection and postoperative hyoxemia were recorded during milrinone administration. Results PAP, PVRI and the incidence of lung infection and PAH were significantly lower, while MAP, SVRI and S(-v)O2higher in group Ⅰ than in group Ⅱ (P < 0.05), but there was no significant difference in the duration of endotracheal tube and incidence of hyoxemia between the two groups(P > 0.05). Conclusion Inhaled aerosolized milrinone has better therapeutic effect than intravenous milrinone on PAH in children with CHD.
4.Analysis of a multiple osteochondroma case caused by novel splice mutation (c.1164+1G to A) of EXT1 gene.
Xiaoyan GUO ; Wenxu CHEN ; Mingrui LIN ; Tengfei SHI ; Dianhua HUANG ; Zhihong WANG
Chinese Journal of Medical Genetics 2017;34(3):411-415
OBJECTIVETo detect potential mutation of EXT1 gene in a pedigree affected with multiple osteochondroma and explore its pathogenic mechanism.
METHODSThe coding regions and their flanking sequences of the EXT1/EXT2 genes were subjected to PCR amplification and Sanger sequencing. Suspected mutations were verified by excluding possible single nucleotide polymorphisms and bioinformatics analysis. Transcripts of the EXT1 gene in the proband were analyzed by TA clone-sequencing, with its abundance compared with that of healthy controls.
RESULTSDNA sequencing has identified in the proband a novel heterozygous point mutation (c.1164+1G to A) at the 5'splice sites of intron 3 of the EXT1 gene. The same mutation was not found in the healthy controls. Bioinformatics analysis indicated that the mutation is highly conserved and can lead to skipping of exon 3 or aberrant splicing. TA clone-sequencing indicated that the numbers of transcripts with skipping of exon 3 has significantly increased in the proband (< 0.05) compared with the controls.
CONCLUSIONThe c.1164+1G to A mutation has resulted in skipping of exon 3 in a proportion of EXT1 gene transcripts. As the result, the number of transcripts with tumor suppressing function is relatively reduced and has ultimately led to the tumors.
Adult ; Base Sequence ; Child ; Exostoses, Multiple Hereditary ; genetics ; Female ; Humans ; Male ; Molecular Sequence Data ; N-Acetylglucosaminyltransferases ; genetics ; Point Mutation ; RNA Splice Sites ; RNA Splicing
5.Analysis and verification of a HLA-DQB1*03:90N allele with a single base deletion.
Zhanrou QUAN ; Hongyan ZOU ; Hao CHEN ; Yanping ZHONG ; Dan ZHOU ; Zhihui DENG ; Wenxu HONG
Chinese Journal of Medical Genetics 2020;37(6):681-684
OBJECTIVE:
To verify a HLA-DQB1*03:90N allele and method to improve the accuracy of HLA typing.
METHODS:
A total of 2265 hematopoietic stem cell donors from Shenzhen Branch of China Marrow Donor Program in 2018 were initially detected by a PCR sequence-specific oligonucleotide probe (SSOP) method. Among these, a rare HLA-DQB1 allele was identified by sequence-based tying (SBT) and Ion Torrent S5 next generation sequencing (NGS).
RESULTS:
The SSOP typing result suggested the HLA-DQB1 to be a rare allele, while an insertion and a deletion was suspected in its exon 2 by SBT, which were confirmed by NGS as DQB1*03:90N and DQB1*06:01, respectively.
CONCLUSION
Rare alleles suspected by the SSOP method should be verified by other methods to ensure the accuracy of HLA genotyping. Rare alleles formed by deletions can be detected by NGS with accuracy.
6.Distribution of KIR/HLA alleles among ethnic Han Chinese patients with hepatocellular carcinoma from southern China.
Suqing GAO ; Baihai JIAO ; Wenxu HONG ; Chuangchuang CAI ; Yanping ZHONG ; Zhanrou QUAN ; Hao CHEN ; Yunping XU
Chinese Journal of Medical Genetics 2019;36(5):439-442
OBJECTIVE:
To assess the association of KIR/HLA alleles with hepatocellular carcinoma (HCC) and hepatitis B virus (HBV) infection among ethnic Han Chinese patients from southern China.
METHODS:
For 95 patients with HCC and 171 healthy controls, the genotype of HLA-C alleles was determined with a PCR sequence-specific oligonucleotides typing method on an Illumina GenDx NGSgo platform. Genotypes comprised of HLA-C and KIR gene alleles were also subjected to statistical analysis.
RESULTS:
In total 16 KIR genes (2DL2, 2DS2, 2DS3, 2DS5, 3DS1, 2DS1, 2DL5, 2DS4, 3DL1, 3DP1, 2DL3, 2DP1, 3DL3, 2DL1, 3DL2 and 2DL4) were discovered in the two groups. The frequencies of KIR2DL3 alleles and combinational genotypes of KIR2DL3/HLA-C1C2 were significantly lower in the patient group compared with the controls (0.9368 vs. 0.9883, χ²>3.84; P<0.05, OR = 0.1; 0.0112 vs. 0.2663, χ²>3.84; P<0.05, RR = 0.03). The frequency of HLA-C2C2 genotype of the patient group was significantly lower than that of the controls (0.0316 vs. 0.2690, P<0.05, RR = 0.09), while the frequency of HLA-C1C2 genotype was significantly higher than that of the controls (0.2316 vs. 0.0058, P<0.05, RR = 51.23).
CONCLUSION
Above results suggested that the KIR2DL3 allele is associated with lower risk for HCC. There may be individual difference in patients with HCC and HBV infection but various combinations of KIR/HLA alleles.
Alleles
;
Carcinoma, Hepatocellular
;
genetics
;
China
;
Gene Frequency
;
Genotype
;
Humans
;
Liver Neoplasms
;
genetics
;
Polymorphism, Genetic
;
Receptors, KIR
7.Cost-utility Analysis of Infliximab in the Treatment of Ulcerative Colitis
Wenxu CHEN ; Di CHEN ; Aizong SHEN
China Pharmacy 2020;31(22):2750-2756
OBJECTIVE:To evaluate the economics of infliximab in the treatment of ulcerative colitis. METHODS :Retrieved from CNKI ,Wanfang database ,VIP,PubMed,Embase database and Cochrane Library since Oct. 16th in 2019,randomized controlled trials (RCTs)about infliximab (trial group )vs. conventional drugs (control group )in the treatment of ulcerative colitis were collected ,and efficacy and safety of two groups were compared by Meta-analysis. The economics were analyzed by cost-utility analysis ,and single factor sensitivity analysis and probability sensitivity analysis were conducted. RESULTS :The results of Meta-analysis showed that clinical response rate [RR =1.97,95% CI (1.64,2.36),P<0.000 01] and clinical remission rate [RR =3.19,95%CI(1.83,5.57),P<0.000 1] in double blind trial subgroup of infliximab treatment were both significantly higher than than control group of conventional treatment. There was no statistical significance in the incidence of severe ADR between 2 groups [RR =0.76,95%CI(0.54,1.06),P=0.10]. The incremental cost-utility ratio of trial group was 348 243.88 yuan/quality-adjusted life-year (QALY),which was significantly higher than the patient ’s willingness to pay threshold (212 676 yuan).The sensitivity analysis supported above results. CONCLUSIONS :Under the current level of medical security in China , compared with conventional therapy ,infliximab is less economical for the treatment of ulcerative colitis.
8.Multicenter study on the effect of early screening skills training for autism spectrum disorders in primary care hospitals in Chengdu
Wenxu YANG ; Jiao LE ; Lan ZHANG ; Ying ZHANG ; Ping YANG ; Chunxia ZHAO ; Chunhua DU ; Junni HE ; Yanmei CAO ; Jia SHANG ; Li LI ; Yan LIU ; Shenglan WU ; Xia LI ; Xiujin CHEN ; Hai LAN ; Hua LI ; Xiang KONG ; Hengli LI ; Defang MI ; Jie ZHAO ; Yang NIE ; Jinxiu GAO ; Ling LI
Sichuan Mental Health 2022;35(4):337-342
ObjectiveTo investigate effect of conducting training of autism spectrum disorder (ASD) early screening skill on improving the ability to early identify ASD of medical staffs in primary care hospitals. MethodsIn September 2021, the training of ASD early screening skills was carried out for medical staffs from 20 primary care hospitals in Chengdu. After training, the training effect was evaluated. The numbers of referrals from primary care hospitals to superior hospitals, confirmed ASD as well as their average diagnostic age of children with ASD before and after training were used as evaluation indicators. ResultsAfter training, the number of children with suspected ASD referred by primary care hospitals was more than that before training [(16.65±11.60) vs. (3.40±2.23), t=5.431, P<0.01], the number of children diagnosed with ASD was more than that before training[(6.85±4.93) vs. (2.45±1.67), t=4.171, P<0.01], and the differences were statistically significant. As for the diagnosed age of ASD children, after training, the average age was lower than that before training [(34.95±11.67) vs. (42.2±14.64), t=-2.553, P=0.019]. ConclusionTraining of ASD early screening skills for medical staffs in primary care hospitals may help to improve their ability to early screening ASD children.